
APCs as Allies: How Drug Delivery Hijacks Immunity
Discover how antigen-presenting cells like dendritic cells and macrophages are being recruited through smart particle design for vaccines and immunotherapy.
Showing results for: "Targeted Drug Delivery" (65 results)

Discover how antigen-presenting cells like dendritic cells and macrophages are being recruited through smart particle design for vaccines and immunotherapy.

Natural polysaccharides like locust bean gum and chitosan are replacing lactose as safer, more effective carriers for inhaled medications and vaccines.

Why is mucus the biggest obstacle to lung drug delivery? Explore the mucosal barrier science reshaping how we design inhaled medicines and vaccines.

Drug repurposing is reshaping medicine. Discover how changing a drug's route of administration — not the molecule itself — can unlock new therapeutic potential.

Nanotechnology is having a big impact on pharmaceutical sciences, and drug delivery systems are one area where this is most evident. Compared to conventional medication delivery methods, nanoparticles provide a number of benefits, including increased effectiveness and fewer adverse drug reactions.

Modern healthcare is undergoing a silent revolution. Now to treat a disease in the healthcare system, there is no longer a need to wait for symptoms to appear.

Inhaled antibiotics deliver drugs directly to lung infections, achieving better results with fewer side effects, which is a game-changer in fighting resistance.

Traditionally, Forensic Science relies on Human DNA for contact evidence and individual identification, but limitation arises when the blood cells obtained from the crime scene are degraded or not.

Smart nanoparticles are an exciting step forward in modern medicine especially nanomedicine. They help doctors be more precise in cancer treatment.

Tuberculosis (TB) remains one of the world's deadliest infectious diseases, claiming over a million lives each year. TB is the deadliest infectious disease known today, claiming more lives than COVID-19. TB is caused by the bacterium Mycobacterium tuberculosis. TB spreads through the air when infected people breathe, cough, sneeze,

Messenger RNA (mRNA) vaccines represent one of the most significant scientific advances in modern therapeutics. Unlike conventional vaccines that use weakened or inactivated pathogens, mRNA vaccines deliver genetic instructions that enable host cells to synthesize a target antigen and stimulate an immune response.

Vancomycin is an essential glycopeptide antibiotic used to treat life-threatening infections caused by Gram-positive bacteria, particularly Methicillin-Resistant Staphylococcus aureus (MRSA). It functions by inhibiting bacterial cell-wall synthesis and is still the most potent drug to be used when others fail (Patel, Preuss, & Bernice, 2023).

Too big, it hits your throat. Too small, you exhale it. The sweet spot delivers drugs exactly where they're needed.

This architecture is essential for shielding neurons from toxins, pathogens, and fluctuations in the bloodstream, but it also creates a devastating bottleneck for modern medicine. More than 98% of small-molecule drugs and nearly all large biological therapeutics fail to cross the BBB in meaningful amounts, leaving many promising treatments for neurodegenerative disorders, brain tumors, and inflammatory diseases stranded in the circulation.

This article aims to demystify the anatomy of a clinical trial protocol, peeling back the technical layers to reveal how scientific rigor is converted into medical progress. At ScientistsHub, we often ask: How do we ensure that a medical breakthrough is not just a stroke of luck, but a repeatable, verifiable victory for human health? The answer is found in the design. To truly appreciate the result of any trial, one must first master the architecture of the inquiry.

How a 150-year-old food industry technique became essential for creating stable biologics and inhaled medicines, transforming liquid drugs into life-saving powders.

The current trajectory of epilepsy management has encountered a formidable "refractory wall." Despite the accelerated expansion of the neuropharmacological pharmacopeia,

Discover how the SNAP29 gene guides cellular traffic, and how its mutation leads to CEDNIK syndrome, affecting brain, nerves, and skin.

Explore the multi-organ cellular mapping of GLP-1 receptor agonists. Discover how GLP-1RAs act as a systemic shield across T2DM, obesity, PMOS, MASH and so on.

Cell and gene therapies represent a seismic shift in healthcare. They promise to cure the incurable, restoring sight to the blind and erasing cancer from the blood. But this frontier is wild. It comes with biological price tags, potential genetic misfires, and a regulatory landscape that is still being mapped.